Australia Neurothrombectomy Devices Market Size & Outlook

Clot retrievers was the largest segment with a revenue share of 58.52% in 2023. Horizon Databook has segmented the Australia neurothrombectomy devices market based on clot retrievers, aspiration/suction devices, vascular snares covering the revenue growth of each sub-segment from 2018 to 2030.

Increasing incidence of stroke and rising healthcare expenditure in Australia are major factors promoting market growth over the forecast period. For instance, as per study published by the Stroke Foundation in 2018, stroke is one of the leading causes of deaths in Australia and in 2017 there were more than 56,000 recurrent and new stroke cases reported in Australia.

Similarly, as per the report published by Australian Institute of Health and Welfare in 2018, around 8,200 deaths were recorded due to stroke, which almost accounted for 5.20% of all deaths in Australia in 2016.

Such instances are anticipated to positively impact the market. In addition, as per the report published by the Australian Institute of Health and Welfare in 2018, government funding is around two-thirds of all healthcare spending and nongovernment funding is around 33.00%. Therefore, such instances may encourage many new and key players to enter the market, thereby propelling the market growth.